Only 1 in 4 Adolescent Treatment Facilities Offer Buprenorphine for Opioid Use Disorder

Only 1 in 4 residential addiction treatment facilities caring for U.S. adolescents under 18 years old offer buprenorphine, a medication used to treat opioid use disorder, according to a new study. Only 1 in 8 offer buprenorphine for ongoing treatment. These findings highlight a significant gap in...

Still Reaching: The Syndemics that Complicate and Characterize How Drugs and HIV Intersect in People’s Lives

Nearly 42 years ago, the Centers for Disease Control and Prevention (CDC) reported a rare pneumonia in five gay men, marking the recognized start of the HIV/AIDS epidemic. While we often hear about those men’s sexuality, we hear less often about their substamce use. As the 1981 report notes,...

Increased Use of Telehealth for OUD Services During COVID-19 Pandemic Associated With Reduced Risk of Overdose

The expansion of telehealth services for opioid use disorder (OUD) during the COVID-19 pandemic was associated with individuals staying in treatment longer and reducing their risk of medically treated overdose, according to a new study. Published today in JAMA Psychiatry, this study was a...

Buprenorphine Initiation in the ER Found Safe and Effective for Individuals With Opioid Use Disorder Who Use Fentanyl

Results from a multi-site clinical trial supported by the National Institutes of Health showed that less than 1% of people with opioid use disorder whose drug use includes fentanyl experienced withdrawal when starting buprenorphine in the ER. The findings, which appeared today in JAMA Network Open,...

Creating Sustainable Homes for Prevention Services

The addiction and overdose crisis in the U.S. continues unabated, with more than 46 million people having a substance use disorder (SUD) in 2021 and more than 100,000 people dying from drug overdose annually. The crisis is increasingly hitting adolescents. Fentanyl, the main driver of overdose...

Overdose Deaths Involving Buprenorphine Did Not Proportionally Increase With New Flexibilities in Prescribing

The proportion of opioid overdose deaths involving buprenorphine, a medication used to treat opioid use disorder, did not increase in the months after prescribing flexibilities were put in place during the COVID-19 pandemic, according to a new study. These data provide evidence that may help to...

School Prevalence of Stimulant Therapy for ADHD Associated With Higher Rates of Prescription Stimulant Misuse Among Teens

Researchers have identified a strong association between the prevalence of prescription stimulant therapy for attention-deficit/hyperactivity disorder (ADHD) and rates of prescription stimulant misuse (taken in a way other than as directed by a clinician) by students in middle and high schools. The...

Time to Start Talking About Pre-Addiction

By the time someone reaches out for addiction care, they may have already suffered numerous painful losses in their lives. Addiction can steal a person’s happiness, job, friends and family, and can erode their freedom. Far too often, the expectation is that someone must hit “rock...

Young Men at Highest Risk of Schizophrenia Linked with Cannabis Use Disorder

Young men with cannabis (marijuana) use disorder have an increased risk of developing schizophrenia, according to a study led by researchers at the Mental Health Services in the Capital Region of Denmark and the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. The...

Five Areas Where “More Research” Isn’t Needed to Curb the Overdose Crisis

“…but more research is needed.” That’s often the refrain in science, and it includes addiction research. As the addiction epidemic and overdose crisis continue to claim an unprecedented number of lives and to fray communities, science is an essential part of the solution. In the...